Wu CW - Search Results

1

Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.

Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL. Chen LT, et al. Among authors: wu cw. J Natl Cancer Inst. 2005 Sep 21;97(18):1345-53. doi: 10.1093/jnci/dji277. J Natl Cancer Inst. 2005. PMID: 16174856

2

A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.

Chen LT, Liu TW, Wu CW, Chung TR, Shiah HS, Jan CM, Liu JM, Whang-Peng J, Chang JY. Chen LT, et al. Among authors: wu cw. Oncology. 2002;63(3):239-47. doi: 10.1159/000065471. Oncology. 2002. PMID: 12381903 Clinical Trial.

3

Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan.

Lin HJ, Perng CL, Lo WC, Wu CW, Tseng GY, Li AF, Sun IC, Ou YH. Lin HJ, et al. Among authors: wu cw. World J Gastroenterol. 2004 Sep 1;10(17):2493-7. doi: 10.3748/wjg.v10.i17.2493. World J Gastroenterol. 2004. PMID: 15300891 Free PMC article.

4

Complications following D3 gastrectomy: post hoc analysis of a randomized trial.

Wu CW, Chang IS, Lo SS, Hsieh MC, Chen JH, Lui WY, Whang-Peng J. Wu CW, et al. World J Surg. 2006 Jan;30(1):12-6. doi: 10.1007/s00268-005-7951-5. World J Surg. 2006. PMID: 16369704 Clinical Trial.

5

Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Wu CW, et al. Lancet Oncol. 2006 Apr;7(4):309-15. doi: 10.1016/S1470-2045(06)70623-4. Lancet Oncol. 2006. PMID: 16574546 Clinical Trial.

6

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.

Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Chang CH, et al. Among authors: wu cw. Arch Surg. 2004 Mar;139(3):320-5; discussion 326. doi: 10.1001/archsurg.139.3.320. Arch Surg. 2004. PMID: 15006892

7

Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.

Chen JH, Wu CW, Kao HL, Chang HM, Li AF, Liu TY, Chi CW. Chen JH, et al. Among authors: wu cw. Cancer Lett. 2006 Aug 8;239(2):263-70. doi: 10.1016/j.canlet.2005.08.026. Epub 2005 Oct 21. Cancer Lett. 2006. PMID: 16243430

8

High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.

Lo SS, Wu CW, Chi CW, Li AF, Chen JH, Lui WY. Lo SS, et al. Among authors: wu cw. Hepatogastroenterology. 2005 Nov-Dec;52(66):1902-4. Hepatogastroenterology. 2005. PMID: 16334803

9

Protein tyrosine-phosphatase expression profiling in gastric cancer tissues.

Wu CW, Kao HL, Li AF, Chi CW, Lin WC. Wu CW, et al. Cancer Lett. 2006 Oct 8;242(1):95-103. doi: 10.1016/j.canlet.2005.10.046. Epub 2005 Dec 7. Cancer Lett. 2006. PMID: 16338072

10

Multiple primary cancers in patients with gastric cancer.

Wu CW, Lo SS, Chen JH, Hsieh MC, Li AF, Lui WY. Wu CW, et al. Hepatogastroenterology. 2006 May-Jun;53(69):463-7. Hepatogastroenterology. 2006. PMID: 16795993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,464 results

Search Page

Filters